Altre lingue Mayne Pharma Group Limited

Azioni

Mercato chiuso - Australian S.E. Altri mercati azionari 08:10:52 18/04/2024			Variaz. 5gg	Var. 1 gen.
6,75 ^AUD	+1,35%		-5,06%	+9,76%

26/02	Mayne Pharma Group registra una perdita nel primo semestre fiscale, nonostante la crescita dei ricavi; le azioni salgono del 15%.	MT
25/02	Transcript : Mayne Pharma Group Limited, H1 2024 Earnings Call, Feb 26, 2024

Lagere omzet Mithra ondanks hogere productomzet	08/03
Mithra zet zichzelf in de etalage	05/03
MAYNE PHARMA REPORTS 1H FY24 RESULTS WITH A 43% INCREASE IN REVENUE TO A$188 MILLION AND $8 MILLION UNDERLYING EBITDA	27/02
Mayne Pharma Group Swings to Loss in Fiscal H1 Despite Revenue Growth; Shares Jump 15%	26/02
Mayne Pharma Group Limited Reports Earnings Results for the Half Year Ended December 31, 2023	25/02
Brussel schudt tegenvallende inflatie data van zich af	17/02
Mithra Pharmaceuticals Exits Stake in Mayne Pharma	16/02
Brussel sluit in het groen	15/02
Chemie en zorgvastgoed trekken de kop	15/02
Kleine winsten in Brussel	15/02
Brusselse beurs opent in het groen	15/02
Mithra verkoopt Mayne Pharma	15/02
An undisclosed buyer acquired a 5.06% stake in Mayne Pharma Group Limited from Mithra Pharmaceuticals SA for AUD 21 million	15/02
Mayne Pharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference	29/12
Mayne Pharma Group Limited Approves Election of Anne Lockwood	30/11
Mithra Pharmaceuticals Obtains US Patent for Contraceptive Pill	07/11
Aanvullend Amerikaans patent voor Mithra	07/11
Mayne Pharma Gets Additional US Patent for Contraceptive	06/11
Mayne Pharma Gets Go-Ahead for Resignation of EY as Auditor	03/11
MAYNE PHARMA PROVIDES UPDATE ON FIRST QUARTER 2024 TRADING AND OUTLOOK	19/10/23

Non ci sono risultati per questa ricerca